Tech Company Financing Transactions
StimOxyGen Funding Round
On 3/11/2025, StimOxyGen secured $2 million in funding from Clarendon Fund Managers, Innovate UK and QUBIS.
Transaction Overview
Company Name
Announced On
3/11/2025
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to advance key preclinical studies, scale-up manufacturing, and expand its team as it moves towards clinical translation.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
School of Pharmacy and Pharmaceutical Sciences Cromore Road
Coleraine Co. Derry/Londonderry, BT52 1SA
UK
Coleraine Co. Derry/Londonderry, BT52 1SA
UK
Phone
Undisclosed
Website
Email Address
Overview
For over 15 years, scientists at Ulster University have been developing stimulus responsive therapeutic systems, primarily to address the adverse effects associated with the use of cancer chemotherapeutic drugs. During those studies, the benefits of providing a transient, in situ source of molecular oxygen during therapy became abundantly clear and it was out of this that StimOxyGen was born.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sian Farrell
Browse more venture capital transactions:
Prev: 3/11/2025: Greenspace Health venture capital transaction
Next: 3/11/2025: Capture6 venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs